Skip to main content
Premium Trial:

Request an Annual Quote

GenomeQuest Raises $4M in Venture Funding

NEW YORK (GenomeWeb News) - GenomeQuest has received $4 million in venture capital funding from new and existing investors, the company said today.
 
The genomic information search company said it plans to use the Series B cash infusion to expand its organization to support sales of the GenomeQuest software and to introduce new product features.
 
This round of funding was led by Mosaix Ventures. Previous investors Cross Atlantic Partners, Milestone Venture Partners, and Societe Generale Asset Management Alternative Investments also participated.
 
The company, formerly known as Gene-IT, received $4.1 million in Series A funding in November 2005
 
GenomeQuest CEO and president Ronald Ranauro said in a statement that the company expects the market for its software to grow as the cost of genomic sequencing drops, and that this round of financing will help the company prepare for that anticipated growth.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.